Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis
S Chicklore, V Goh, M Siddique, A Roy… - European journal of …, 2013 - Springer
Abstract 18 F-Fluorodeoxyglucose positron emission tomography/computed tomography (18
F-FDG PET/CT) is now routinely used in oncological imaging for diagnosis and staging and …
F-FDG PET/CT) is now routinely used in oncological imaging for diagnosis and staging and …
Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC …
[18F]-fluorodeoxyglucose ([18F]-FDG) uptake is enhanced in most malignant tumours which
in turn can be measured using positron emission tomography (PET). A number of small …
in turn can be measured using positron emission tomography (PET). A number of small …
[HTML][HTML] ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
Abstract The European Society for Medical Oncology (ESMO) consensus conference on
testicular cancer was held on 3–5 November 2016 in Paris, France. The conference …
testicular cancer was held on 3–5 November 2016 in Paris, France. The conference …
2-18fluoro-deoxy-D-glucose Positron Emission Tomography Is a Reliable Predictor for Viable Tumor in Postchemotherapy Seminoma: An Update of the Prospective …
M De Santis, A Becherer, C Bokemeyer… - Journal of Clinical …, 2004 - ascopubs.org
Purpose To define the clinical value of 2-18fluoro-deoxy-D-glucose positron emission
tomography (FDG PET) as a predictor for viable residual tumor in postchemotherapy …
tomography (FDG PET) as a predictor for viable residual tumor in postchemotherapy …
Molecular imaging and its biological applications
ME Phelps - Eur J Nucl Med Mol Imaging, 2004 - Springer
This book is written as both a text and a reference book. It contains numerous images from
the biological sciences and clinical practice, tables, graphs, and fig ures, as well as …
the biological sciences and clinical practice, tables, graphs, and fig ures, as well as …
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging
GJR Cook, EA Wegner, I Fogelman - Seminars in nuclear medicine, 2004 - Elsevier
It is estimated that in excess of one million positron emission tomography (PET) scans are
performed each year and PET can now truly be regarded as a routine imaging procedure in …
performed each year and PET can now truly be regarded as a routine imaging procedure in …
[HTML][HTML] 2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the …
M Bachner, Y Loriot, M Gross-Goupil, PA Zucali… - Annals of oncology, 2012 - Elsevier
ABSTRACT Background 2-18 fluoro-deoxy-D-glucose positron emission tomography (FDG-
PET) has been recommended in international guidelines in the evaluation of …
PET) has been recommended in international guidelines in the evaluation of …
[18F]Fluorodeoxyglucose Positron Emission Tomography in Nonseminomatous Germ Cell Tumors After Chemotherapy: The German Multicenter Positron Emission …
K Oechsle, M Hartmann, W Brenner, S Venz… - Journal of Clinical …, 2008 - ascopubs.org
Purpose In patients with metastatic nonseminomatous germ cell cancer (NSGCT), residual
masses after chemotherapy (CTX) can consist of vital carcinoma, mature teratoma, or …
masses after chemotherapy (CTX) can consist of vital carcinoma, mature teratoma, or …
Relevance of positron emission tomography (PET) in oncology
Hintergrund: Die Positronenemissionstomographie (PET) wird zunehmend in der Diagnostik
onkologischer Erkrankungen eingesetzt. Auch in der Therapiekontrolle von Strahlen-und …
onkologischer Erkrankungen eingesetzt. Auch in der Therapiekontrolle von Strahlen-und …